Gene Therapy Market Research Reports & Industry Analysis
Gene therapy is an innovative field with the potential to develop new, personalized medical treatments for previously challenging conditions. At MarketResearch.com, we are committed to providing you with comprehensive gene therapy industry reports that shed light on this fast-growing market.
Understanding the Gene Therapy Market
- Our gene therapy market research reports provide valuable insights into this dynamic field to help you understand the key factors at play, prepare for challenges, and leverage technological advancements.
- Our research collection covers various markets—such as gene therapy, precision medicine, delivery devices, and manufacturing services—with data on market size and growth projections.
- In addition, we also delve into market segmentation, key developments, industry trends, and company profiling to give you the full picture of the market.
Helping You Stay Ahead
Whether you're an experienced industry professional, a consultant, or a busy executive, our gene therapy market research reports provide valuable insights. These reports are based on reliable data and expert analysis to help you make informed business decisions. With MarketResearch.com, you can stay ahead of the competition and take advantage of emerging market opportunities.
Gene Therapy Industry Research & Market Reports
-
Asia-Pacific Cell and Gene Therapy Manufacturing QC Market: Analysis and Forecast, 2023-2033
... million in 2023 and is expected to reach $2,233.6 million by 2033, growing at a CAGR of 18.01% during the forecast period 2023-2033. The cell and gene therapy manufacturing quality control (QC) market is projected ... Read More
-
Regenerative Medicine Market by Product (Stem Cell [Autologous, Allogenic], Immunotherapy, Gene Therapy, Tissue Engineering), Application (Musculoskeletal, Cancer, Dermatology, Wound care, Cardiovascular Diseases, Eye Disorders) - Global Forecast to 2028
... projected to reach USD 49.0 Billion by 2028 from USD 16.0 Billion in 2023, at a CAGR of 25.1% during the forecast period of 2023 to 2028. Factors such as the wide scope in new ... Read More
-
Viral Vector Manufacturing Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)
... The global market for viral vector manufacturing has witnessed remarkable growth over the past decade. In 2024, the market recorded revenue of US$ 800 million, and it is projected to reach a valuation of US$ ... Read More
-
Rare Disease Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)
... North America Leads with a Dominant Market Share The global rare disease treatment market is on an upward trajectory, with the genetic diseases segment expected to maintain its dominance in the coming years, according to ... Read More
-
Cell & Gene Therapy Manufacturing Services Global Market Report 2024
... Application: Commercial Manufacturing; Clinical Manufacturing4) By End-user: Academic And Research Institutes; Pharmaceutical And Biotechnology CompaniesCovering: Thermo Fisher Scientific Inc.; Merck KGaA; Charles River Laboratories International Inc.; Lonza Group AG; Catalent Inc. Cell & Gene Therapy ... Read More
-
Translational Regenerative Medicine Market by Product Type (Cell Based Product, Gene Therapy Product, Tissue Engineered Product), Application (Cardiovascular, Dermatology, Diabetes) - Global Forecast 2024-2030
... billion in 2023 and expected to reach USD 3.36 billion in 2024, at a CAGR 11.48% to reach USD 6.46 billion by 2030. Global Translational Regenerative Medicine Market FPNV Positioning Matrix The FPNV Positioning Matrix ... Read More
-
Viral Vectors Market by Type (Adeno-associated Viral Vectors, Adenoviral Vectors, Retroviral Vectors), Disease (Cancers, Genetic Disorders, Infectious Diseases), Application, End User - Global Forecast 2024-2030
... billion in 2023 and expected to reach USD 1.88 billion in 2024, at a CAGR 14.09% to reach USD 4.18 billion by 2030. Global Viral Vectors Market FPNV Positioning Matrix The FPNV Positioning Matrix is ... Read More
-
Asia Pacific Cell and Gene Therapy Manufacturing Services Market Forecast to 2030 - Regional Analysis - by Type [Cell Therapy (Autologous and Allogenic) and Gene Therapy (Viral and Non-Viral Vector)], Indication (Cancer, Orthopedics, and Others), Application (Clinical Manufacturing and Commercial Manufacturing), and End User [Pharmaceutical and Biotechnology Companies and Contract Research Organization (CROs)]
... Application (Clinical Manufacturing and Commercial Manufacturing), and End User [Pharmaceutical and Biotechnology Companies and Contract Research Organization (CROs)] The Asia Pacific cell and gene therapy manufacturing services market is expected to grow from US$ 1,007.42 ... Read More
-
Cell & Gene Therapy Drug Delivery Devices Market by Products (Extension Tube, Infusion Bags, Intravenous Catheter), Commercialized Drugs (Kymriah, Luxturna, Provenge) - Global Forecast 2024-2030
... was estimated at USD 1.08 billion in 2023 and expected to reach USD 1.17 billion in 2024, at a CAGR 9.78% to reach USD 2.08 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix ... Read More
-
Cell & Gene Therapy Market by Product (Cell Therapy, Gene Therapy), Delivery Method (Ex Vivo, In Vivo), Application, End-User - Global Forecast 2024-2030
... billion in 2023 and expected to reach USD 34.63 billion in 2024, at a CAGR 25.39% to reach USD 135.04 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the ... Read More
-
Middle East & Africa Cell and Gene Therapy Manufacturing Services Market Forecast to 2030 - Regional Analysis - by Type [Cell Therapy (Autologous and Allogenic) and Gene Therapy (Viral and Non-Viral Vector)], Indication (Cancer, Orthopedics, and Others), Application (Clinical Manufacturing and Commercial Manufacturing), and End User [Pharmaceutical and Biotechnology Companies and Contract Research Organization (CROs)]
... and Others), Application (Clinical Manufacturing and Commercial Manufacturing), and End User [Pharmaceutical and Biotechnology Companies and Contract Research Organization (CROs)] The Middle East & Africa cell and gene therapy manufacturing services market is expected to ... Read More
-
Cancer Gene Therapy Market by Therapy (Gene Induced Immunotherapy, Gene Transfer, Oncolytic Virotherapy), Indication (Breast Cancer, Liver Cancer, Lung Cancer), End-Use - Global Forecast 2024-2030
... 2.20 billion in 2023 and expected to reach USD 2.75 billion in 2024, at a CAGR 20.22% to reach USD 7.99 billion by 2030. Global Cancer Gene Therapy Market FPNV Positioning Matrix The FPNV Positioning ... Read More
-
Advanced Therapy Medicinal Products CDMO Market by Products (Cell Therapy, Gene Therapy, Tissue Engineered), Phase (Phase I, Phase II, Phase III), Indication, End-Users - Global Forecast 2024-2030
... was estimated at USD 7.54 billion in 2023 and expected to reach USD 8.74 billion in 2024, at a CAGR 17.06% to reach USD 22.74 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix ... Read More
-
Regenerative Medicine Market by Type (Cell-Based Immunotherapy & Cell Therapy Products, Gene Therapy Products, Small Molecule & Biologic), Application (Cardiovascular, Diabetes, Musculoskeletal Disorders) - Global Forecast 2024-2030
... USD 24.01 billion in 2023 and expected to reach USD 28.82 billion in 2024, at a CAGR 20.13% to reach USD 86.73 billion by 2030. Global Regenerative Medicine Market FPNV Positioning Matrix The FPNV Positioning ... Read More
-
Viral Vector Manufacturing Market by Type (Adeno-associated Viral Vectors, Adenoviral Vectors, Lentiviral Vectors), Disease (Cancer, Genetic Disorders, Infectious Diseases), Application - Global Forecast 2024-2030
... billion in 2023 and expected to reach USD 1.25 billion in 2024, at a CAGR 19.11% to reach USD 3.59 billion by 2030. Global Viral Vector Manufacturing Market FPNV Positioning Matrix The FPNV Positioning Matrix ... Read More
-
Oncology Precision Medicine Market by Type (Cell & Gene Therapy, Inhibitor drugs, Monoclonal Antibodies), Cancer Type (Breast Cancer, Cervical Cancer, Colorectal Cancer), End-use - Global Forecast 2024-2030
... at USD 7.34 billion in 2023 and expected to reach USD 7.67 billion in 2024, at a CAGR 9.10% to reach USD 13.51 billion by 2030. Global Oncology Precision Medicine Market FPNV Positioning Matrix The ... Read More
-
North America Cell and Gene Therapy Manufacturing Services Market Forecast to 2030 - Regional Analysis - by Type [Cell Therapy (Autologous and Allogenic) and Gene Therapy (Viral and Non-Viral Vector)], Indication (Cancer, Orthopedics, and Others), Application (Clinical Manufacturing and Commercial Manufacturing), and End User [Pharmaceutical and Biotechnology Companies and Contract Research Organization (CROs)]
... Application (Clinical Manufacturing and Commercial Manufacturing), and End User [Pharmaceutical and Biotechnology Companies and Contract Research Organization (CROs)] The North America cell and gene therapy manufacturing services market is expected to grow from US$ 4,153.27 ... Read More
-
South & Central America Cell and Gene Therapy Manufacturing Services Market Forecast to 2030 - Regional Analysis - by Type [Cell Therapy (Autologous and Allogenic) and Gene Therapy (Viral and Non-Viral Vector)], Indication (Cancer, Orthopedics, and Others), Application (Clinical Manufacturing and Commercial Manufacturing), and End User [Pharmaceutical and Biotechnology Companies and Contract Research Organization (CROs)]
... and Others), Application (Clinical Manufacturing and Commercial Manufacturing), and End User [Pharmaceutical and Biotechnology Companies and Contract Research Organization (CROs)] The South & Central America cell and gene therapy manufacturing services market is expected to ... Read More
-
Cell & Gene Therapy Clinical Trials Market by Phase (Phase I, Phase II, Phase III), Application (Cardiology, CNS, Dermatology) - Global Forecast 2024-2030
... USD 6.67 billion in 2023 and expected to reach USD 7.53 billion in 2024, at a CAGR 13.36% to reach USD 16.05 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in ... Read More
-
Europe Cell and Gene Therapy Manufacturing Services Market Forecast to 2030 - Regional Analysis - by Type [Cell Therapy (Autologous and Allogenic) and Gene Therapy (Viral and Non-Viral Vector)], Indication (Cancer, Orthopedics, and Others), Application (Clinical Manufacturing and Commercial Manufacturing), and End User [Pharmaceutical and Biotechnology Companies and Contract Research Organization (CROs)]
... (Clinical Manufacturing and Commercial Manufacturing), and End User [Pharmaceutical and Biotechnology Companies and Contract Research Organization (CROs)] The Europe cell and gene therapy manufacturing services market is expected to grow from US$ 1,879.77 million in ... Read More
-
Gene Cloning Services Market by Service (Custom Cloning Service, Gene Synthesis Service, Molecular Biology Service), Application (Gene Expression, Gene Synthesis, Gene Therapy), End User - Global Forecast 2024-2030
... estimated at USD 2.38 billion in 2023 and expected to reach USD 2.63 billion in 2024, at a CAGR 11.96% to reach USD 5.25 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is ... Read More
-
Brain Tumor Therapeutics Market by Type (Glioblastoma, Meningioma, Metastatic Brain Tumors), Therapy (Chemotherapy, Gene Therapy, Immunotherapy), Patient Age Group, Distribution Channel, End-User - Global Forecast 2024-2030
... USD 3.03 billion in 2023 and expected to reach USD 3.28 billion in 2024, at a CAGR 8.24% to reach USD 5.28 billion by 2030. Global Brain Tumor Therapeutics Market FPNV Positioning Matrix The FPNV ... Read More
-
Bladder Cancer Therapeutics Market by Treatment Type (Chemotherapy, Gene Therapy, Immunotherapy), Bladder Cancer Type (Invasive Bladder Cancer, Squamous Cell Bladder Cancer, Superficial Bladder Cancer), End-User - Global Forecast 2024-2030
... was estimated at USD 5.21 billion in 2023 and expected to reach USD 5.56 billion in 2024, at a CAGR 7.23% to reach USD 8.49 billion by 2030. Global Bladder Cancer Therapeutics Market FPNV Positioning ... Read More
-
Cell & Gene Therapy Biomanufacturing CDMO Market by Component (Cell Therapy, Plasmid DNA, Viral Vector), Phase (Phase 1, Phase 2, Phase 3), Indication - Global Forecast 2024-2030
... size was estimated at USD 338.12 million in 2023 and expected to reach USD 485.47 million in 2024, at a CAGR 32.53% to reach USD 2,428.90 million by 2030. FPNV Positioning Matrix The FPNV Positioning ... Read More
-
Cell and Gene Therapy Manufacturing Market Report: Trends, Forecast and Competitive Analysis to 2030
... with opportunities in the pharmaceutical & biotechnology company and academic & research institute markets. The global cell and gene therapy manufacturing market is expected to reach an estimated $19.1 billion by 2030 with a CAGR ... Read More
Research Assistance
